Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pasteur Mérieux Sérum et Vaccins was a preeminent French vaccine manufacturer that evolved through several mergers to become Sanofi Pasteur, and is now the global vaccine business unit of Sanofi. The company has a storied history dating back to the work of Louis Pasteur and Marcel Mérieux, focusing on the development and production of life-saving vaccines for infectious diseases. Its portfolio includes vaccines for influenza, polio, rabies, and various pediatric diseases, serving markets worldwide. Today, as part of Sanofi, it continues to be one of the largest producers of vaccines globally, maintaining significant R&D and manufacturing facilities in France and North America. The company's legacy includes the successful development of the first inactivated polio vaccine and the first rabies vaccine produced in cell culture. Its current operations are at the forefront of vaccine innovation, including the development of next-generation mRNA and recombinant protein technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pasteur Mérieux Sérum et Vaccins.